Hims & Hers Health (HIMS) Other financing activities (2019 - 2026)
Hims & Hers Health (HIMS) posted Other financing activities of $5.0 million for Q1 2026, up 44.32% sequentially from $3.5 million in Q4 2025, and up 27.49% YoY from $3.9 million in Q1 2025.
Hims & Hers Health (HIMS) Other financing activities (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Other financing activities for 7 years, with the latest figure at $5.0 million in Q1 2026.
- Quarterly Other financing activities rose 27.49% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (down 70.52% YoY) and the FY2025 annual result came in at $6.4 million, down 75.84% from the prior year.
- Other financing activities advanced to $5.0 million in Q1 2026 per HIMS's latest filing, from $3.5 million in the prior quarter.
- Over five years, Other financing activities peaked at $16.9 million in Q3 2024 and troughed at -$3.4 million in Q2 2024.
- A 5-year average of $2.7 million and a median of $891000.0 in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 1969.39% in 2024, down 628.02% in 2024.
- Over 5 years, Other financing activities stood at -$2.2 million in 2022, then soared by 166.02% to $1.4 million in 2023, then soared by 472.05% to $8.1 million in 2024, then tumbled by 57.4% to $3.5 million in 2025, then surged by 44.32% to $5.0 million in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $5.0 million, $3.5 million, and -$958000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Hims & Hers Health | 7.81 Bn | 6.97 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.02 Mn |
| Jun 30, 2026 | 8.02 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Jun 30, 2025 | -958,000.00 |
| Jun 30, 2025 | -958,000.00 |
| Mar 31, 2025 | 3.93 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Sep 30, 2024 | 16.88 Mn |
| Sep 30, 2024 | 16.88 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Mar 31, 2024 | 5.07 Mn |
| Mar 31, 2024 | 5.07 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |